157 related articles for article (PubMed ID: 35316153)
1. Autoimmunity Is a Significant Feature of Idiopathic Pulmonary Arterial Hypertension.
Jones RJ; De Bie EMDD; Groves E; Zalewska KI; Swietlik EM; Treacy CM; Martin JM; Polwarth G; Li W; Guo J; Baxendale HE; Coleman S; Savinykh N; Coghlan JG; Corris PA; Howard LS; Johnson MK; Church C; Kiely DG; Lawrie A; Lordan JL; Mackenzie Ross RV; Pepke Zaba J; Wilkins MR; Wort SJ; Fiorillo E; Orrù V; Cucca F; Rhodes CJ; Gräf S; Morrell NW; McKinney EF; Wallace C; Toshner M;
Am J Respir Crit Care Med; 2022 Jul; 206(1):81-93. PubMed ID: 35316153
[No Abstract] [Full Text] [Related]
2. Circulating plasmablasts are elevated and produce pathogenic anti-endothelial cell autoantibodies in idiopathic pulmonary arterial hypertension.
Blum LK; Cao RRL; Sweatt AJ; Bill M; Lahey LJ; Hsi AC; Lee CS; Kongpachith S; Ju CH; Mao R; Wong HH; Nicolls MR; Zamanian RT; Robinson WH
Eur J Immunol; 2018 May; 48(5):874-884. PubMed ID: 29369345
[TBL] [Abstract][Full Text] [Related]
3. Missense mutations of the BMPR1B (ALK6) gene in childhood idiopathic pulmonary arterial hypertension.
Chida A; Shintani M; Nakayama T; Furutani Y; Hayama E; Inai K; Saji T; Nonoyama S; Nakanishi T
Circ J; 2012; 76(6):1501-8. PubMed ID: 22374147
[TBL] [Abstract][Full Text] [Related]
4. Whole-exome sequencing reveals TopBP1 as a novel gene in idiopathic pulmonary arterial hypertension.
de Jesus Perez VA; Yuan K; Lyuksyutova MA; Dewey F; Orcholski ME; Shuffle EM; Mathur M; Yancy L; Rojas V; Li CG; Cao A; Alastalo TP; Khazeni N; Cimprich KA; Butte AJ; Ashley E; Zamanian RT
Am J Respir Crit Care Med; 2014 May; 189(10):1260-72. PubMed ID: 24702692
[TBL] [Abstract][Full Text] [Related]
5. Hemodynamic and clinical onset in patients with hereditary pulmonary arterial hypertension and BMPR2 mutations.
Pfarr N; Szamalek-Hoegel J; Fischer C; Hinderhofer K; Nagel C; Ehlken N; Tiede H; Olschewski H; Reichenberger F; Ghofrani AH; Seeger W; Grünig E
Respir Res; 2011 Jul; 12(1):99. PubMed ID: 21801371
[TBL] [Abstract][Full Text] [Related]
6. Codependence of Bone Morphogenetic Protein Receptor 2 and Transforming Growth Factor-β in Elastic Fiber Assembly and Its Perturbation in Pulmonary Arterial Hypertension.
Tojais NF; Cao A; Lai YJ; Wang L; Chen PI; Alcazar MAA; de Jesus Perez VA; Hopper RK; Rhodes CJ; Bill MA; Sakai LY; Rabinovitch M
Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1559-1569. PubMed ID: 28619995
[TBL] [Abstract][Full Text] [Related]
7. Association of Rare PTGIS Variants With Susceptibility and Pulmonary Vascular Response in Patients With Idiopathic Pulmonary Arterial Hypertension.
Wang XJ; Xu XQ; Sun K; Liu KQ; Li SQ; Jiang X; Zhao QH; Wang L; Peng FH; Ye J; Wu Y; Jiang R; Zhang J; Huang W; Wei WB; Yan Y; Li JH; Liu QQ; Li S; Wang Y; Zhang SY; Zhang X; Jing ZC
JAMA Cardiol; 2020 Jun; 5(6):677-684. PubMed ID: 32236489
[TBL] [Abstract][Full Text] [Related]
8. Loss of immune homeostasis in patients with idiopathic pulmonary arterial hypertension.
Heukels P; Corneth OBJ; van Uden D; van Hulst JAC; van den Toorn LM; van den Bosch AE; Wijsenbeek MS; Boomars KA; Kool M; Hendriks RW
Thorax; 2021 Dec; 76(12):1209-1218. PubMed ID: 33963088
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of childhood pulmonary arterial hypertension in BMPR2 and ALK1 mutation carriers.
Chida A; Shintani M; Yagi H; Fujiwara M; Kojima Y; Sato H; Imamura S; Yokozawa M; Onodera N; Horigome H; Kobayashi T; Hatai Y; Nakayama T; Fukushima H; Nishiyama M; Doi S; Ono Y; Yasukouchi S; Ichida F; Fujimoto K; Ohtsuki S; Teshima H; Kawano T; Nomura Y; Gu H; Ishiwata T; Furutani Y; Inai K; Saji T; Matsuoka R; Nonoyama S; Nakanishi T
Am J Cardiol; 2012 Aug; 110(4):586-93. PubMed ID: 22632830
[TBL] [Abstract][Full Text] [Related]
10. Sequence variants in BMPR2 and genes involved in the serotonin and nitric oxide pathways in idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: relation to clinical parameters and comparison with left heart disease.
Ulrich S; Szamalek-Hoegel J; Hersberger M; Fischler M; Garcia JS; Huber LC; Grünig E; Janssen B; Speich R
Respiration; 2010; 79(4):279-87. PubMed ID: 19844076
[TBL] [Abstract][Full Text] [Related]
11. Iron deficiency and raised hepcidin in idiopathic pulmonary arterial hypertension: clinical prevalence, outcomes, and mechanistic insights.
Rhodes CJ; Howard LS; Busbridge M; Ashby D; Kondili E; Gibbs JS; Wharton J; Wilkins MR
J Am Coll Cardiol; 2011 Jul; 58(3):300-9. PubMed ID: 21737024
[TBL] [Abstract][Full Text] [Related]
12. Serotonin transporter polymorphisms in familial and idiopathic pulmonary arterial hypertension.
Willers ED; Newman JH; Loyd JE; Robbins IM; Wheeler LA; Prince MA; Stanton KC; Cogan JA; Runo JR; Byrne D; Humbert M; Simonneau G; Sztrymf B; Morse JA; Knowles JA; Roberts KE; McElroy JJ; Barst RJ; Phillips JA
Am J Respir Crit Care Med; 2006 Apr; 173(7):798-802. PubMed ID: 16339917
[TBL] [Abstract][Full Text] [Related]
13. Safety and Efficacy of Immunoadsorption as an Add-On to Medical Treatment in Patients with Severe Idiopathic Pulmonary Arterial Hypertension.
Nagel C; Ewert R; Egenlauf B; Lehmkuhl HB; Rosenkranz S; Benjamin N; Schwenger V; Herth FJF; Grünig E
Respiration; 2017; 94(3):263-271. PubMed ID: 28787715
[TBL] [Abstract][Full Text] [Related]
14. Clinical implications of determining BMPR2 mutation status in a large cohort of children and adults with pulmonary arterial hypertension.
Rosenzweig EB; Morse JH; Knowles JA; Chada KK; Khan AM; Roberts KE; McElroy JJ; Juskiw NK; Mallory NC; Rich S; Diamond B; Barst RJ
J Heart Lung Transplant; 2008 Jun; 27(6):668-74. PubMed ID: 18503968
[TBL] [Abstract][Full Text] [Related]
15. Clinical implications of idiopathic pulmonary arterial hypertension phenotypes defined by cluster analysis.
Badagliacca R; Rischard F; Papa S; Kubba S; Vanderpool R; Yuan JX; Garcia JGN; Airhart S; Poscia R; Pezzuto B; Manzi G; Miotti C; Luongo F; Scoccia G; Sciomer S; Torre R; Fedele F; Vizza CD
J Heart Lung Transplant; 2020 Apr; 39(4):310-320. PubMed ID: 32061507
[TBL] [Abstract][Full Text] [Related]
16. Genetics and genomics of pulmonary arterial hypertension.
Soubrier F; Chung WK; Machado R; Grünig E; Aldred M; Geraci M; Loyd JE; Elliott CG; Trembath RC; Newman JH; Humbert M
J Am Coll Cardiol; 2013 Dec; 62(25 Suppl):D13-21. PubMed ID: 24355637
[TBL] [Abstract][Full Text] [Related]
17. Bone morphogenetic protein receptor-2 signaling promotes pulmonary arterial endothelial cell survival: implications for loss-of-function mutations in the pathogenesis of pulmonary hypertension.
Teichert-Kuliszewska K; Kutryk MJ; Kuliszewski MA; Karoubi G; Courtman DW; Zucco L; Granton J; Stewart DJ
Circ Res; 2006 Feb; 98(2):209-17. PubMed ID: 16357305
[TBL] [Abstract][Full Text] [Related]
18. Leptin and regulatory T-lymphocytes in idiopathic pulmonary arterial hypertension.
Huertas A; Tu L; Gambaryan N; Girerd B; Perros F; Montani D; Fabre D; Fadel E; Eddahibi S; Cohen-Kaminsky S; Guignabert C; Humbert M
Eur Respir J; 2012 Oct; 40(4):895-904. PubMed ID: 22362850
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and clinical features of bone morphogenetic protein receptor type 2 mutation in Korean idiopathic pulmonary arterial hypertension patients: The PILGRIM explorative cohort.
Jang AY; Kim BG; Kwon S; Seo J; Kim HK; Chang HJ; Chang SA; Cho GY; Rhee SJ; Jung HO; Kim KH; Seo HS; Kim KH; Shin J; Lee JS; Kim M; Lee YJ; Chung WJ
PLoS One; 2020; 15(9):e0238698. PubMed ID: 32966279
[TBL] [Abstract][Full Text] [Related]
20. The role of inflammation and autoimmunity in the pathophysiology of pulmonary arterial hypertension.
Kherbeck N; Tamby MC; Bussone G; Dib H; Perros F; Humbert M; Mouthon L
Clin Rev Allergy Immunol; 2013 Feb; 44(1):31-8. PubMed ID: 21394427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
